Navigation Links
Joint Venture Formed to Help Health Marketers Navigate Social Media Environment
Date:10/28/2009

NEW YORK, Oct. 28 /PRNewswire/ -- Extrovertic and Virilion announced today a joint venture, EV Healthcare, to help healthcare companies engage consumers in an increasingly social communications environment.

(Logo: http://www.newscom.com/cgi-bin/prnh/20091028/PH00703LOGO )

"Innovating to meet the perpetually evolving needs of digital, social and mobile consumers is hard enough," says Dorothy Wetzel, co-founder and executive marketer at Extrovertic. "Doing it in the politically and emotionally charged healthcare arena is the ultimate challenge. But with Virilion's more than a decade of experience dealing with cause-related issues and crisis management, this venture greatly enhances our ability to create new 'pharma-safe' solutions that build brands."

"Virilion has long specialized in digital and social media for categories in the public eye," said Dan Solomon, CEO of Virilion. "We believe this competence, combined with Extrovertic's deep healthcare knowledge and creative acumen, will help pharma clients more effectively engage consumers in today's changing communications environment."

"DTC advertising is under assault. Clients today need new non-traditional creative solutions to help them tell more cohesive and engaging stories across all channels," added Mark Drossman, Extrovertic's co-founder and executive creative director, "and in the process, create more engaged brand advocates."

Extrovertic was founded by industry veterans Dorothy Wetzel -- formerly of Saatchi Healthcare and Pfizer Consumer Marketing -- and Mark Drossman -- formerly of Ogilvy and Euro RSCG -- in January. The agency's client roster includes a number of biotech companies.

Virilion has offices in Austin, Boston, New York and Washington, DC. Since 1997, the firm has worked for clients in categories ranging from food, agriculture and energy to media and entertainment. In the healthcare sector, Virilion has worked for Abbott, the Pharmaceutical Manufacturers of America, and Easter Seals.

EV Healthcare will be led out of the firms' New York offices.

    CONTACT: Mimi Carter, Publicist
    VIRILION
    mcarter@virilion.com
    202.654.0800

SOURCE EV Healthcare


'/>"/>
SOURCE EV Healthcare
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. New Study Demonstrates ACTEMRA(R) (tocilizumab) Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients
2. Joint Commission Urges Patients to Speak Up About Pain
3. Novexel to Present Five Posters at the Joint Annual Interscience Conference on Antimicrobial Agents and Chemotherapy and the Infectious Disease Society of America (ICAAC/IDSA) Meeting
4. New Study Demonstrated ACTEMRA(R) (tocilizumab) Inhibited Progression of Joint Damage in Rheumatoid Arthritis Patients
5. Rib-X Pharmaceuticals Reports Positive Phase 2 Study Results for Next Generation Oxazolidinone at 2008 ICAAC/IDSA Joint Meeting
6. Texas Back Institute Leads Way in New Facet Joint Clinical Trial
7. AstraZeneca Responds to FDA Joint Advisory Committees Recommendation on SYMBICORT(R)
8. Orthopaedic Surgeon Shortage Predicted Due to Soaring Joint Replacement Procedures
9. When to Have That Joint Replacement?
10. Beating Blood Clots after Joint Replacement
11. Octogenarians: Not Too Old for Joint Replacement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... Md. , March 27, 2017  ImMAGE Biotherapeutics ... its immunotherapy successfully passed early toxicology and efficacy studies. ... system to target a specific protein, MAGE A, in ... negative breast cancer. After 4 weeks ... able to show very little toxicity in a full ...
(Date:3/27/2017)... STUTTGART, Germany , March 27, 2017 /PRNewswire/ ... provide over 7,000 attendees and more than 600 ... learn, and discover opportunities and solutions that will ... - 6 April 2017 at the Messe Stuttgart, ... is the preeminent medical technology platform showcasing the ...
(Date:3/27/2017)... CHICAGO , March 27, 2017  A ... Educators (AADE) found that Medicare,s Competitive Bidding Program (CBP) ... diabetes testing supplies. The lack of choice forces beneficiaries ... can have dire health consequences. AADE,s ... reports by AADE and others pointing out the inherent ...
Breaking Medicine Technology:
(Date:3/28/2017)... ... 28, 2017 , ... Columbus OH. Dr. Justin Harper, Founder of Juvly Aesthetics ... in the country to sit on the 2017 National Advisory Board for Allergan’s Facial ... Dr. Harper helped propel the clinic from a small start-up to number 78 in ...
(Date:3/28/2017)... ... March 28, 2017 , ... AutismOne announced the Board ... of Integrative Medicine and available for application on Saturday, May 27, 2017, following ... in Colorado Springs. , Ed Arranga, president of AutismOne, stated: "Many of the ...
(Date:3/28/2017)... Square, PA (PRWEB) , ... March 28, 2017 , ... ... online and across a variety of business channels. , While many results are ... of any public relations program. , When it comes to measurement, firms should ...
(Date:3/28/2017)... Perry, GA (PRWEB) , ... March 28, 2017 , ... ... headquarters to Marshallville, Georgia, in early March. , The seed processing plant opened in ... the location since 2016. The new office allows opportunity for transition of Patten Seed ...
(Date:3/28/2017)... NY (PRWEB) , ... March 28, 2017 , ... Oily skin is a common and ... Advanced Dermatology has a lot to offer to the discussion of dealing with ... news is that there are many home remedies that can help remove the oily shine ...
Breaking Medicine News(10 mins):